Bhat A, Bhat M, Prasad K, Trivedi D, Acharya S. Estimation of Pyruvic acid in serum and saliva among healthy and potentially malignant disorder subjects – a stepping stone for cancer screening?. J Clin Exp Dent. 2015;7(4):e462-5.

doi:10.4317/jced.52266

http://dx.doi.org/doi:10.4317/jced.52266

References

1. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317-23.
http://dx.doi.org/10.1016/j.oraloncology.2008.05.016
PMid:18674954

2. Sankaranarayanan R, Mathew B, Jacob B, Thomas G, Somanathan T, Pisani P, et al. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. Cancer. 2000;88:664-73
http://dx.doi.org/10.1002/(SICI)1097-0142(20000201)88:3<664::AID-CNCR25>3.0.CO;2-V

PMid:10649262

3. Kujan O, Glenny AM, Duxbury J, Thakker N, Sloan P. Evaluation of screening strategies for improving oral cancer mortality: a Cochrane systematic review. J Dent Educ. 2005;69:255-65.
PMid:15689610

4. McLeod NM, Saeed NR, Ali EA. Oral cancer: delays in referral and diagnosis persist. Br Dent J. 2005;198:681-84.
http://dx.doi.org/10.1038/sj.bdj.4812381
PMid:15951773

5. Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006;66:8927-30.
http://dx.doi.org/10.1158/0008-5472.CAN-06-1501
PMid:16982728

6. Scatena R, Bottoni P, Pontoglio A, Giardina B. Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy. Proteomics Clin Appl. 2010;4:143-58.
http://dx.doi.org/10.1002/prca.200900157
PMid:21137040

7. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drugresistance associated withmitochondrial respiratory defect and hipoxia. Cancer Res. 2005;65:613-21.
PMid:15695406

8. Zu XL, Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun. 2004;313:459-65.
http://dx.doi.org/10.1016/j.bbrc.2003.11.136

PMid:14697210

9. Hammerman PS, Fox CJ, Thompson CB. Beginnings of a signaltransduction pathway for bioenergetics control of cell survival. Trends Biochem Sci. 2004;29:586-92.
http://dx.doi.org/10.1016/j.tibs.2004.09.008
PMid:15501677

10. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007;274:1393-418.
http://dx.doi.org/10.1111/j.1742-4658.2007.05686.x
PMid:17302740

11. Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res.2006;66:8927-30.

PMid:16982728

12. Garber K. Energy deregulation: licensing tumor to grow. Science. 2006;312:1158–9.
http://dx.doi.org/10.1126/science.312.5777.1158
PMid:16728625

13. Gottschalk S, Anderson N, Hainz C, Eckhardt SG, Serkova NJ. Imatinib (STI571) – mediated changes in glucose metabolism in human leukaemia BCR-ABL-positive cells. Clin Cancer Res. 2004;10:6661-8.
http://dx.doi.org/10.1158/1078-0432.CCR-04-0039
PMid:15475456

14. Costello LC, Franklin RB. Why do tumour cells glycolyse from glycolysis?:through citrate to lipogenesis. Mol. Cell Biochem. 2005;280:1-8.
http://dx.doi.org/10.1007/s11010-005-8841-8

PMid:16511951

15. Shaw RJ. Glucose metabolism and cancer. Curr. Opin. Cell Biol. 2006;18:598-608.
http://dx.doi.org/10.1016/j.ceb.2006.10.005
PMid:17046224

16. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell. 2008;13:472-82.
http://dx.doi.org/10.1016/j.ccr.2008.05.005
PMid:18538731

17. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 2008;18:54-61.
http://dx.doi.org/10.1016/j.gde.2008.02.003
PMid:18387799 PMCid:PMC2476215

18. Henze K, Martin W. Evolutionary biology: essence of Mitocondria. Nature. 2003;426:127-8.
http://dx.doi.org/10.1038/426127a
PMid:14614484